Development requirements and regulatory guidance for biosimilars and biobetters.
Christina Satterwhite, PhD
Advertisement
Articles by Christina Satterwhite, PhD
Advertisement
Latest Updated Articles
Assessing Development Needs for Biobetters and BiosimilarsPublished: February 1st 2013 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Establishing Risk Assessments for AI in Bio-Manufacturing
4
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
5
